STEPHANIE NGUYEN: Open Payments
NPI 1316257314 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,210 in 174 payments from 24 companies in 2025. Trend: 2023 $3,636 · 2024 $3,882 · 2025 $4,210
Food & beverage: $4,138Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $575 |
| UCB, Inc. | 21 | $572 |
| ABBVIE INC. | 15 | $458 |
| Galderma Laboratories, L.P. | 10 | $357 |
| Amgen Inc. | 11 | $318 |
| Arcutis Biotherapeutics, Inc. | 29 | $284 |
| Novartis Pharmaceuticals Corporation | 12 | $266 |
| LEO Pharma Inc. | 8 | $217 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $209 |
| PFIZER INC. | 7 | $203 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, OTEZLA, Zoryve, SKYRIZI, RINVOQ, CIBINQO.
Industry payments across TX — which companies pay providers there.
